Is there any clinical significance of compression of left common iliac vein?

Yoon Soon Lee

doi:10.3802/jgo.2014.25.1.1

Deep venous thrombosis (DVT) has been noted to occur as much as 60% more frequently in the left lower extremity than in the right extremity [1]. Virchow first suggested this disparity in 1851 when he observed that iliofemoral vein thrombosis was five times more likely to occur in the left leg than in the right leg [2]. In 1957, May and Thurner [3] pathologic changes at the points where the right common iliac artery crosses over the left common iliac artery. They found that the right iliac artery compressed the left iliac vein against the fifth lumbar vertebra in 22% of 430 cadavers. A recent large number of study using computed tomography showed that mean percentage of compression was 36.6%: 29.7% (66/222) of greater than 50% compression and 7.2% (16/222) of greater than 70% compression [4]. They concluded that increasing levels of percentage compression were not associated with left-sided DVT up to 70%; however, greater than 70% compression might be associated with left DVT. The results of this study are consistent with those of previous smaller studies on iliac vein compression [5,6]. However, Kibbe et al. [7] reported that hemodynamically significant left common iliac vein compression is a frequent anatomic variant in asymptomatic individuals. Hence, they concluded that compression of the left iliac vein might represent a normal anatomic pattern that has thus far been thought as a pathologic condition.

Several studies have demonstrated that therapeutic roles of lymphadenectomy in endometrial cancer and cervical cancer [8-10]. Moreover, extended systematic lymph node dissection resulted in high regional tumor control and high metastatic lymph node rate in cervical cancer [11,12]. To perform the extended systematic lymphadenectomy, it is important to know the exact anatomy of major retroperitoneal vascular structure. Kose et al. [13] demonstrated that prevalence of major retroperitoneal vascular structure anomalies was 17% and common iliac artery and/or vein anomalies was 1.8%. Presence of these anomalies may lead to devastating complications resulting in organ loss or death. However, a few data on anomalies of common iliac vessels are available.

Cancer patients are at increased risk of venous thromboembolism and pulmonary embolism. For prediction of venous thromboembolism, several biomarkers were introduced including blood count analysis (elevated leukocyte and platelet count and decreased hemoglobin), D-dimer, prothrombin fragment, soluble P-selectin, and clotting factor VII [14]. Furthermore, risk assessment models were developed that include clinical and laboratory markers. From a clinical perspective, it would be helpful to have biomarkers that enable early identification of cancer patients at risk of venous thromboembolism and to target anticoagulation for primary prevention of venous thormboembolism based on risk stratification.

In summary, severe compression of the common iliac vein may be associated with left-sided DVT. We should be concerned about the degree of compression to the common iliac vein during systematic para-aortic and pelvic lymphadenectomy for the treatment of gynecologic cancer patients. To prevent life threatening bleeding during systematic lymphadenectomy, it is important to know the exact anatomy of major retroperitoneal vascular structure including common iliac vessels [15]. Thromboprophylaxis is considered to reduce venous thromoembolism using several biomarkers and clinical parameters.

Notes

This editorial was solicited and has not been peer reviewed.

No potential conflict of interest relevant to this article was reported.

References

1. Fazel R, Froehlich JB, Williams DM, Saint S, Nallamothu BK. Clinical problem-solving: a sinister development--a 35-year-old woman presented to the emergency department with a 2-day history of progressive swelling and pain in her left leg, without antecedent trauma. N Engl J Med. 2007; 357:53–59.

2. Virchow R. Uber die Erweiterung kleiner Gefasse. Arch Path Anat. 1851; 3:427.

3. May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957; 8:419–427.

4. Narayan A, Eng J, Carmi L, McGrane S, Ahmed M, Sharrett AR. Iliac vein compression as risk factor for left-versus right-sided deep venous thrombosis: case-control study. Radiology. 2012; 265:949–957.

5. Fraser DG, Moody AR, Martel A, Morgan PS. Re-evaluation of iliac compression syndrome using magnetic resonance imaging in patients with acute deep venous thromboses. J Vasc Surg. 2004; 40:604–611.

6. Oguzkurt L, Ozkan U, Ulusan S, Koc Z, Tercan F. Compression of the left common iliac vein in asymptomatic subjects and patients with left iliofemoral deep vein thrombosis. J Vasc Interv Radiol. 2008; 19:366–370.

7. Kibbe MR, Ujiki M, Goodwin AL, Eskandari M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004; 39:937–943.

8. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23:3668–3675.

9. Pieterse QD, Kenter GG, Gaarenstroom KN, Peters AA, Willems SM, Fleuren GJ, et al. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol. 2007; 33:216–221.

10. Shah M, Lewin SN, Deutsch I, Burke WM, Sun X, Herzog TJ, et al. Therapeutic role of lymphadenectomy for cervical cancer. Cancer. 2011; 117:310–317.

11. Hockel M, Horn LC, Manthey N, Braumann UD, Wolf U, Teichmann G, et al. Resection of the embryologically defined uterovaginal (Mullerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol. 2009; 10:683–692.

12. Lee YS, Chong GO, Lee YH, Hong DG, Cho YL, Park IS. Robot-assisted total preservation of the pelvic autonomic nerve with extended systematic lymphadenectomy as part of nerve-sparing radical hysterectomy for cervical cancer. Int J Gynecol Cancer. 2013; 23:1133–1138.

13. Kose MF, Turan T, Karasu Y, Gundogdu B, Boran N, Tulunay G. Anomalies of major retroperitoneal vascular structure. Int J Gynecol Cancer. 2011; 21:1312–1319.

14. Pabinger I, Thaler J, Ay C. Biomarkers for prediction of venous thromboembolism in cancer. Blood. 2013; 122:2011–2018.

15. Kato K, Tate S, Nishikimi K, Shozu M. Surgical anatomy of the common iliac veins during para-aortic and pelvic lymphadenectomy for gynecologic cancer. J Gynecol Oncol. 2014; 25:64–69.